Nanoparticles and Inflammation

The development of nanoscale molecular probes capable of diagnosis, characterization, and clinical treatment of disease is leading to a new generation of imaging technologies. Such probes are particularly relevant to inflammation, where the detection of subclinical, early disease states could facili...

Full description

Saved in:
Bibliographic Details
Main Authors: Ross Stevenson, Axel J. Hueber, Alan Hutton, Iain B. McInnes, Duncan Graham
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2011.106
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566742115680256
author Ross Stevenson
Axel J. Hueber
Alan Hutton
Iain B. McInnes
Duncan Graham
author_facet Ross Stevenson
Axel J. Hueber
Alan Hutton
Iain B. McInnes
Duncan Graham
author_sort Ross Stevenson
collection DOAJ
description The development of nanoscale molecular probes capable of diagnosis, characterization, and clinical treatment of disease is leading to a new generation of imaging technologies. Such probes are particularly relevant to inflammation, where the detection of subclinical, early disease states could facilitate speedier detection that could yield enhanced, tailored therapies. Nanoparticles offer robust platforms capable of sensitive detection, and early research has indicated their suitability for the detection of vascular activation and cellular recruitment at subclinical levels. This suggests that nanoparticle techniques may provide excellent biomarkers for the diagnosis and progression of inflammatory diseases with magnetic resonance imaging (MRI), fluorescent quantum dots (QDs), and surface enhanced Raman scattering (SERS) probes being just some of the new methodologies employed. Development of these techniques could lead to a range of sensitive probes capable of ultrasensitive, localized detection of inflammation. This article will discuss the merits of each approach, with a general overview to their applicability in inflammatory diseases.
format Article
id doaj-art-265c752474c441a693ec212b189916ff
institution Kabale University
issn 1537-744X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-265c752474c441a693ec212b189916ff2025-02-03T01:03:15ZengWileyThe Scientific World Journal1537-744X2011-01-01111300131210.1100/tsw.2011.106Nanoparticles and InflammationRoss Stevenson0Axel J. Hueber1Alan Hutton2Iain B. McInnes3Duncan Graham4Centre for Molecular Nanometrology, Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, UKCentre for Rheumatic Diseases, University of Glasgow, Glasgow, UKCentre for Molecular Nanometrology, Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, UKCentre for Rheumatic Diseases, University of Glasgow, Glasgow, UKCentre for Molecular Nanometrology, Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, UKThe development of nanoscale molecular probes capable of diagnosis, characterization, and clinical treatment of disease is leading to a new generation of imaging technologies. Such probes are particularly relevant to inflammation, where the detection of subclinical, early disease states could facilitate speedier detection that could yield enhanced, tailored therapies. Nanoparticles offer robust platforms capable of sensitive detection, and early research has indicated their suitability for the detection of vascular activation and cellular recruitment at subclinical levels. This suggests that nanoparticle techniques may provide excellent biomarkers for the diagnosis and progression of inflammatory diseases with magnetic resonance imaging (MRI), fluorescent quantum dots (QDs), and surface enhanced Raman scattering (SERS) probes being just some of the new methodologies employed. Development of these techniques could lead to a range of sensitive probes capable of ultrasensitive, localized detection of inflammation. This article will discuss the merits of each approach, with a general overview to their applicability in inflammatory diseases.http://dx.doi.org/10.1100/tsw.2011.106
spellingShingle Ross Stevenson
Axel J. Hueber
Alan Hutton
Iain B. McInnes
Duncan Graham
Nanoparticles and Inflammation
The Scientific World Journal
title Nanoparticles and Inflammation
title_full Nanoparticles and Inflammation
title_fullStr Nanoparticles and Inflammation
title_full_unstemmed Nanoparticles and Inflammation
title_short Nanoparticles and Inflammation
title_sort nanoparticles and inflammation
url http://dx.doi.org/10.1100/tsw.2011.106
work_keys_str_mv AT rossstevenson nanoparticlesandinflammation
AT axeljhueber nanoparticlesandinflammation
AT alanhutton nanoparticlesandinflammation
AT iainbmcinnes nanoparticlesandinflammation
AT duncangraham nanoparticlesandinflammation